Updated Jul 16, 2026
Ribas Antoni has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Ribas Antoni is listed as a director of Arcus Biosciences, Inc. in SEC filings as of May 12, 2026. Public biographical information in the SEC context is limited, and the identity may correspond to Antoni Ribas, a well-known cancer researcher, though this is not confirmed by the SEC materials. Further verification from Arcus Biosciences’ leadership or investor relations materials is recommended to confirm biographical details and avoid name confusion.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | RCUS | Arcus Biosciences, Inc. | A — Grant or award | 5.7K | $0.00 | |
| 2026-05-12 | RCUS | Arcus Biosciences, Inc. | G — Bona-fide gift | 5.0K | $0.00 |
Ribas Antoni is listed as a director of Arcus Biosciences, Inc. in SEC filings as of May 12, 2026. Public biographical information in the SEC context is limited, and the identity may correspond to Antoni Ribas, a well-known cancer researcher, though this is not confirmed by the SEC materials. Further verification from Arcus Biosciences’ leadership or investor relations material…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ribas Antoni profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.